Cargando…
Human Mesenchymal Stem Cell Secretome Driven T Cell Immunomodulation Is IL-10 Dependent
The Human Mesenchymal Stem Cell (hMSC) secretome has pleiotropic effects underpinning its therapeutic potential. hMSC serum-free conditioned media (SFCM) contains a variety of cytokines, with previous studies linking a changed secretome composition to physoxia. The Jurkat T cell model allowed the ef...
Autores principales: | Shephard, Matthew T., Merkhan, Marwan M., Forsyth, Nicholas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658100/ https://www.ncbi.nlm.nih.gov/pubmed/36362383 http://dx.doi.org/10.3390/ijms232113596 |
Ejemplares similares
-
Physoxia alters human mesenchymal stem cell secretome
por: Merkhan, Marwan M, et al.
Publicado: (2021) -
Mesenchymal Stem Cells Secretory Responses: Senescence Messaging Secretome and Immunomodulation Perspective
por: Lunyak, Victoria V., et al.
Publicado: (2017) -
Hypoxia Pre-Conditioned Embryonic Mesenchymal Stem Cell Secretome Reduces IL-10 Production by Peripheral Blood Mononuclear Cells
por: Lotfinia, Majid, et al.
Publicado: (2017) -
Harnessing the Helminth Secretome for Therapeutic Immunomodulators
por: Ditgen, Dana, et al.
Publicado: (2014) -
The Secretome of Preconditioned Mesenchymal Stem Cells Drives Polarization and Reprogramming of M2a Macrophages toward an IL-10-Producing Phenotype
por: Holthaus, Michelle, et al.
Publicado: (2022)